IP Library Granted Patent US 6,849,455
Granted Patent B1
US 6,849,455 · App. 09/888,373 · Granted Feb 1, 2005

Enhanced recovery of transformed cells

Assignee: New York University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,849,455
App. No.
09/888,373
Granted
Feb 1, 2005
Kind
B1
Abstract

DNA is efficiently transformed into a host by electroporation in the presence of a methylation package, which greatly improves the efficiency of the transformation. The methylation package comprises a source of cysteine, such as cysteine, homocysteine, or glutathione, with optional iron and magnesium ions.

Claims (10)

1. In a method for transferring DNA into host cells comprising subjecting said host cells to electroporation in the presence of said DNA, the improvement comprising conducting said electroporation, adding homocysteine to the cells immediately following electroporation and during selection, and adding a source of cysteine during selection.

2. The method according to claim 1 wherein the cysteine during selection is present in an amount of 400 micrograms/ml.

3. The method according to claim 1 wherein the source of cysteine is selected from the group consisting of cysteine and glutathione.

4. The method according to claim 1 wherein the medium further contains ferrous sulfate and magnesium ion.

5. The method according to claim 1 wherein the host is E. coli.

6. The method according to claim 4 wherein the magnesium ion is present as magnesium sulfate.

7. The method according to claim 5 wherein the DNA is transferred using a replicon selected from the group consisting of plasmids which replicate in E. coli.

8. A kit for replication comprising a polylinker with a plurality of restriction sites, a source of cysteine for selection, and a combination of homocysteine, ferrous sulfate, and magnesium ion.

9. The kit according to claim 8 wherein the magnesium ion is present as magnesium sulfate.

10. The kit according to claim 8 further comprising a plasmid replicon selected from the group consisting of plasmids which replicate in E. coli.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 3, 2022
From: NEW YORK UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 061286/0333 →
CONFIRMATORY LICENSE Recorded May 8, 2008
From: NEW YORK UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020918/0649 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2003
From: MAAS, RENATA
To: NEW YORK UNIVERSITY
Reel/Frame 013877/0032 →
Continuity (1)
Provisional Application 6022667300 · Aug 22, 2000